Increased Levels of Fibrinolysis Reaction Products (D-Dimer) in Patients with Decompensated Alcoholic Liver Cirrhosis

References

• Zetterquist E, von Franken I. Coagulation disturbances with manifest bleeding in extrahepatic portal hypertension and in liver cirrhosis. Acta Med Scand 1963; 173: 753–760
   PubMedGoogle Scholar
• Boks A L, Brommer E JP, Schalm S W, van Vliet H HDM. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage. Hepatology 1986; 6: 79–86
   PubMed Web of Science ®Google Scholar
• Joist J H. Hemostatic abnormalities in liver disease. Hemostatis and thrombosis, R W Colman, J Hirsch, V J Marder, E W Salzman. JB Lippincott Company, Philadelphia 1987; 861–872
   Google Scholar
• Oka K, Tanaka K. Intravascular coagulation in autopsy cases with liver disease. Thromb Haemost 1979; 42: 564–570
   PubMed Web of Science ®Google Scholar
• Brodsky I, Siegel N H, Kahn S B, et al. Simultaneous flbrinogen and platelet survival with 75Se selenomethiomine in man: studies in diseases with normal coagulation and in hepatocellular disease with abnormal coagulation. Br J Haematol 1970; 18: 341–355
   PubMed Web of Science ®Google Scholar
• Stein S F, Karker L A. Kinetic and functional studies of platelets fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med 1982; 99: 217–230
   PubMed Web of Science ®Google Scholar
• Thomas D P, Ream V J, Stuart R K. Platelet aggregation in patients with Laennec's cirrhosis of the liver. N Engl J Med 1967; 276: 1344–1348
   PubMed Web of Science ®Google Scholar
• Zurborn K-H, Gram J, Rohwedder E, Bewig B, Bruhn H D. Der Einfluss der Lebercirrhose auf die Aktivierung des Gerinnungs- und Fibrinolyse-systems und auf die Gerinnungs-inhibitoren. Med Klin 1989; 84: 515–518
   Google Scholar
• Tytgat G N, Collen D, Verstraete M. Metabolism of fibrinogen in cirrhosis of the liver. J Clin Invest 1971; 50: 1690–1701
   PubMed Web of Science ®Google Scholar
• Verstraete M, Vermylen J, Collen D. Intravascular coagulation in liver disease. Ann Rev Med 1974; 25: 447–455
   PubMed Web of Science ®Google Scholar
• Marongiu F, Mamusa A M, Mameli G, et al. α2-Antiplasmin and disseminated intravascular coagulation in liver cirrhosis. Thromb Res 1985; 37: 287–294
   PubMed Web of Science ®Google Scholar
• Marongiu F, Mameli G, Acca M R, et al. Fibrinopeptide A and Bβ 15–47 in liver cirrhosis. Haemostasis 1988; 18: 126–128
   PubMedGoogle Scholar
• Astrup T, Rasmussen J, Amery A, Poulsen H E. Fibrinolytic activity of cirrhotic liver. Nature 1960; 185: 619–620
   PubMed Web of Science ®Google Scholar
• Fletcher A P, Biederman O, Moore D, Alkjaersig N, Sherry S. Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis: its cases and consequences. J Clin Invest 1964; 43: 681–695
   PubMed Web of Science ®Google Scholar
• Mombelli G, Monotti R, Haeberli A, Straub P W. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC, and various non-thromboembolic diseases. Thromb Haemost 1987; 58: 758–763
   PubMed Web of Science ®Google Scholar
• Leebeek F WG, Kluft C, Knot E AR, Maat M PM. Inappropriate inhibition at the plasmin level may contribute to enhanced fibrinolysis in advanced liver cirrhosis. Fibrinolysis 1988; 2(suppl 3)75–78
   Google Scholar
• Jespersen J. Liver biopsy in relation to haemostasis tests and bleeding risk. Fibrinolysis 1988; 2(suppl 3)51–55
   Google Scholar
• Jespersen J, Knudsen L H, Sidelmann J. The use of evacuated glass tubes for collection of blood samples for fibrinolytic assays. Thromb Res 1982; 25: 173–176
   PubMed Web of Science ®Google Scholar
• Hoek J A, Sturk A, ten Gate J W, Lamping R J, Berends F, Borm J J. Laboratory and clinical evaluation of thrombin-antithrombin III complexes in plasma. Clin Chem 1988; 34: 2058–2062
   PubMed Web of Science ®Google Scholar
• Stötzer K-E, Amiral J, Spanuth E. Neue Methoden zur spezifischen Bestimmung von Fibrinspaltprodukten (D-dimer). Lab Med 1988; 12: 51–59
   Google Scholar
• Verheijen J H, Mullaart E, Chang G TG, et al. A simple sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982; 48: 266–269
   PubMed Web of Science ®Google Scholar
• Gram J, Jespersen J. A simplified estimation of tissue plasminogen activator (t-PA) inhibition in human plasma. Fibrinolysis 1987; 1: 33–37
   Google Scholar
• Bloom A L. Intravascular coagulation and the liver. Br J Haematol 1975; 30: 1–8
   PubMed Web of Science ®Google Scholar
• Mombelli G, Monotti R, Haeberli A, Straub P W. Low grade DIG in liver cirrhosis: fact or fiction. Thromb Haemost 1988; 59: 345
   Web of Science ®Google Scholar
• Astrup T, Jespersen J. Thrombosis, disseminated intravascular coagulation, and the dynamic haemostatic balance. Int Angiol 1984; 3: 331–342
   Web of Science ®Google Scholar
• Jespersen J. Pathophysiology and clinical aspects of disseminated intravascular coagulation. Antithrombin deficiency, L E Böttiger. KabiVitrum, Stockholm 1986; 65–77
   Google Scholar
• Dzirk W H, Arkin C F, Jenkins R L, Stump D C. Fibrinolysis during liver transplantation in humans: role of tissue type plasminogen activator. Blood 1988; 71: 1090–1095
   PubMed Web of Science ®Google Scholar
• Porte R J. Hemostatic disorders in orthotopic and auxiliary liver transplantation. Clinical and experimental studies. Thesis, ICG Printing, DordrechtThe Netherlands 1989; 1–191
   Google Scholar
• Booth N A, Bennett B, Wijngaards G, Grieve J HK. A new life-long hemorrhagic disorder due to excess plasminogen activator. Blood 1983; 61: 267–275
   PubMed Web of Science ®Google Scholar
• Walther P J, Gore M, Pizzo S V. Increased releasable vascular plasminogen activator and a bleeding diathesis. Am J Med 1984; 77: 566–568
   PubMed Web of Science ®Google Scholar